- This event has passed.
Research on Hep C Identification & Treatment Among Persons who Inject Drugs
April 8 @ 3:00 pm - 4:30 pm EDT
Collaborative Research on Hepatitis C Identification and Treatment among Persons Who Inject Drugs
Thursday, April 8th
3-4:30 pm ET
The United States National Institutes of Health (NIH) is committed to setting research priorities that advance progress toward viral hepatitis elimination. In 2020, Dr. Harvey Alter, NIH researcher, was awarded the Nobel Prize in Medicine and Physiology for his contributions to the discovery of HCV, exemplifying the importance of NIH to hepatitis elimination efforts.
NIH and the Coalition for Global Hepatitis Elimination are launching a new webinar series, “Moving from Hepatitis Discovery to Elimination” to highlight ongoing research that can benefit elimination efforts, support translation of research into implementation, and identify additional research needs.
This webinar on April 8th will highlight ongoing research by the National Institute on Drug Abuse (NIDA) advancing hepatitis elimination among people who use drugs and incarcerated populations.
Presentations will include:
“The Kentucky Viral Hepatitis Treatment Study (KeY Treat)”
-Dr. Jennifer Havens, Professor, College of Medicine, Center on Drug and Alcohol Research, University of Kentucky
“Impact of HCV treatment in HIV/HCV co-infected and mono-infected incarcerated persons”
-Dr. Risha Irvin, Assistant Professor, School of Medicine, John Hopkins University
“HIV, HCV and Related Comorbidities in Rural Communities Affected by Opioid Injection Drug Epidemics in the United States: Building Systems for Prevention, Treatment and Control”
-Dr. Todd M. Allen, Professor of Medicine, Harvard Medical School, Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital